Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Luis Borrero-Garcia"'
Autor:
Luis Borrero Garcia, Anamaris Torres-Sanchez, Patricia Sanchez-Orive, Suranganie Dharmawardhane
Publikováno v:
Journal of Biological Chemistry. 299:103331
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c52fc92ff788419cd577ded4b071cf44
https://doi.org/10.1016/j.jbc.2023.103331
https://doi.org/10.1016/j.jbc.2023.103331
Autor:
Surangani Dharmawardhane, JI Medina-Vlazquez, Linette Castillo-Pichardo, Pablo E. Vivas-Mejia, Jean F. Ruiz-Calderon, LE Velazquez-Vega, Michael John Rivera-Robles, Luis Borrero-Garcia, MdM Maldonado
Publikováno v:
Cancer Research. 79:P6-21
Breast cancer metastasis, when cancer cells move and establish tumors in distant organs, confounds treatment options. Therefore, there is an unmet need for targeted therapeutics to address metastasis, especially in the intractable HER2 positive (+) b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::57f68e58e0398e5b6bc9946be7a89619
https://doi.org/10.1158/1538-7445.sabcs18-p6-21-14
https://doi.org/10.1158/1538-7445.sabcs18-p6-21-14
Autor:
Mary Helen Barcellos-Hoff, Alba Gonzalez-Junca, Oliver Reiners, Luis Borrero Garcia, Hideho Okada
Publikováno v:
Neuro Oncol
SB28 is a new luciferase expressing murine glioblastoma (GBM) cell line whose morphology, growth pattern, mutational burden immune infiltrate more closely resembles human GBM and is unresponsive to immunotherapy (OncoImmunology, 7:12, e1501137). Radi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d1f0dc3c5cea1951adc580b5984cfbb7
https://europepmc.org/articles/PMC6847635/
https://europepmc.org/articles/PMC6847635/
Autor:
Cornelis Vlaar, Surangani Dharmawardhane, Luis A. Cubano, Linette Castillo-Pichardo, Fabiola Pagan Melendez, Luis Borrero-Garcia, Eliud Hernandez, Ingrid Forrestier-Roman, Tessa Humphries-Bickley
Publikováno v:
Cancer Research. 76:3076-3076
The expression and activities of the Rho GTPases Rac and Cdc42, and their downstream effector P21-activated kinase (PAK), have been correlated with metastatic cancer. Our published studies with the Rac/PAK inhibitor EHop-016 demonstrate the validity
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3a18cdcaa2542e0679deb2966e14282e
https://doi.org/10.1158/1538-7445.am2016-3076
https://doi.org/10.1158/1538-7445.am2016-3076
Autor:
Eliud Hernandez-O'Farrill, Luis A. Cubano, Linette Castillo-Pichardo, Suranganie Dharmawardhane, Cornelis Vlaar, Luis Borrero-Garcia, Ingrid S. Forestier-Román, Tessa Humphries-Bickley
Publikováno v:
Molecular Cancer Therapeutics. 14:A141-A141
The Rho GTPase Rac is a pivotal regulator of cancer cell migration and invasion; processes required for metastatic progression. We previously characterized the small molecule EHop-016 as a novel Rac inhibitor in metastatic breast cancer cells and rec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a113d8f1a94f845f44cce92481aa000b
https://doi.org/10.1158/1535-7163.targ-15-a141
https://doi.org/10.1158/1535-7163.targ-15-a141